期刊文献+

芳氧基-芳酰基哌嗪取代乙胺丙醇类α,β受体双阻滞剂的合成 被引量:1

Synthesis of 1-phenoxy-3-(2-piperizinyl)ethylamino-2- propanol for possessing α,β-receptor inhibitors
下载PDF
导出
摘要 目的设计合成具有α、β受体双阻滞作用的系列化合物 ,并进行活性的初步筛选。 方法运用系列化电子等排原理 ,设计合成了系列 1 芳氧基 3 [2 (4 芳酰基哌嗪 )乙氨基 ] 2 丙醇衍生物 ,并经MS、1H NMR、IR确证其结构。结果与结论合成了 15个目标化合物 ,其中 12个为新化合物 ,初步活性测定结果显示 :所合成的化合物均具有α、β受体双阻滞作用。 Aim To design and synthesize a series of compounds possessing α,β -receptor inhibitors.Methods According to the enssitial principal and drug design methods,fifteen compounds of 1-phenoxy-3-(2-piperizinyl)ethylamino-2-propanol were designed and synthesized as α,β -receptor inhibitors.The structures of the compounds were determined by elemental analysis, 1H-NMR and IR.Their activity was tested.Results and Conclusion Fifteen compounds were designed and synthesized,twelve compounds are new compounds.The activity test shows that some compounds have fairly potent α,β -receptor blocking activity.
机构地区 郑州大学化学系
出处 《中国药物化学杂志》 CAS CSCD 2003年第3期142-145,共4页 Chinese Journal of Medicinal Chemistry
关键词 药物化学 制备 化学合成 Α-受体阻滞剂 Β-受体阻滞剂 1-芳氧基-3-[2-(4-芳酰基哌嗪)乙氨基]-2-丙醇衍生物 medicinal chemistry preparation chemical synthesis α,β -receptor blocking inhibitor 1-phenoxy-3-(2-piperizinyl)ethylamino-2-propanol derivatives
  • 相关文献

参考文献5

二级参考文献10

共引文献35

同被引文献11

  • 1朱文玲.腺苷在心血管病诊治中的应用前景[J].中华心血管病杂志,2004,32(10):948-951. 被引量:17
  • 2Robak T. New nucleoside analogs for patients with he-matological malignancies[ J]. Expert Opinion on Inves-tigational Drugs,2011,20(3) :343 -359.
  • 3Tran H, Yang D_ Qofarabine in the treatment of newlydiagnosed acute myeloid leukemia in older adults [J]. HieAnnals of Phannacolherapy ,2012,46( 1) :89 - 96.
  • 4Schreiner T L, Miravalle A. Current and emerging(6)Schreiner T L, Miravalle A. Current and emergingtherapies for the treatment of multiple sclerosis : Focuson cladribine [ J ] ? Journal of central nervous systemdisease ,2012,4:1 - 14.
  • 5Polotskaia K, Hoffman S, Krett N L, et al. 8-amino-adenosine activates p53-independent cell death of me-tastatic breast cancers [ J ]. Molecular Cancer Thera-peutics,2012,11( 11) ;2495 -2504.
  • 6Ketan M. Synthesis and screening of 2-[2-(‘substi-tuted piperazine-1 -yl ) -5-phenylthiazol-4-yl ] -3-arylquinazolinone derivatives as anti cancer agents[ J].Journal of drug discovery and therapeutics, 2013,1(7):84 -89.
  • 7赵圣印,邵志宇,谢志雄.3-哌嗓基-吲哚马来酰亚胺化合物及其制备和应用[P]. CN102 924 437,2013.
  • 8万红贵,郭一丹,蔡恒,郑伟刚.S-腺苷甲硫氨酸研究进展及市场应用分析[J].现代生物医学进展,2008,8(10):1951-1955. 被引量:6
  • 9刘畅,李文娟,陈瑜,丁卫,安国顺,李淑艳,倪菊华,贾弘禔.8-氯腺苷诱导的组蛋白H3K79双甲基化促进NBS1和p21的基因转录激活[J].中国生物化学与分子生物学报,2009,25(11):1035-1040. 被引量:1
  • 10张逸伟,刘子奇,林东恩.新型5'-脱氧核苷衍生物的合成[J].合成化学,2012,20(3):349-351. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部